Fungal Infections in Cancer Patients

References

• De Gregorio M, Lee W, Linker C, et al. Fungal infections in patients with acute leukemia. Am J Med 1982; 73: 543–548
   PubMed Web of Science ®Google Scholar
• Hawkins C, Armstrong D. Fungal infections in the immunocom-promised host. Clin Haematol 1984; 13: 599–630
   PubMedGoogle Scholar
• Walsh T J, Pizzo PA. Nosocomial fungal infections. Ann Rev Microbiol 1988; 42: 517–547
   PubMed Web of Science ®Google Scholar
• Bodey G. Candidiasis: a growing concern. Am J Med 1984; 77: 1–48, suppl 4D
   Web of Science ®Google Scholar
• Odds FC. Candida and Candidiasis: A Review and Bibliography2nd ed. Saunders, London 1988; 1–468
   Google Scholar
• Tashjian L S, Abramson J S, Peacock JE. Focal hepatic candidiasis: A distinct clinical variant of candidiasis in immunocompromised patients. Rev Infect Dis 1984; 6: 689–703
   PubMedGoogle Scholar
• Haron E, Feld R, Tuffnell P, et al. Hepatic candidiasis: An increasing problem in immunocompromised patients. Am J Med 1987; 83: 17–26
   PubMed Web of Science ®Google Scholar
• Thaler M, Pastakia B, Shawker TH, et al. Hepatic candidiasis in cancer patients. The evolving picture of the syndrome. Ann Intern Med 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Meunier-Carpentier F, Kiehn T, Armstrong D. Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med 1981; 1: 363–370
   Google Scholar
• Horn R, Wong B, Kiehn TE, et al. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985; 7: 646–655
   PubMedGoogle Scholar
• Meunier-Carpentier F. Significance and clinical manifestations of fungemia. Infections in Cancer Patients, J Klastersky. Raven Press, New York 1982; vol. 10: 141–155
   Google Scholar
• Edwards JE. Candida endophtalmitis. Current Clinical Topics in Infectious Diseases, JS Remington, MN Swartz. McGraw Hill, New York 1982; vol. 3: 381–397
   Google Scholar
• Wingard J, Merz W, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 1979; 91: 539–543
   PubMed Web of Science ®Google Scholar
• Aisner J, Schimpff S, Sutherland J, et al. Torulopsis glabrata infections in patients with cancer increasing incidence and relationship to colonization. Am J Med 1976; 61: 23–28
   PubMed Web of Science ®Google Scholar
• Aisner J, Murillo J, Schimpff SC, et al. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979; 90: 4–9
   PubMed Web of Science ®Google Scholar
• Fischer Bs., Armstrong D, Yu B. Invasive aspergillosis: progress in early diagnosis and treatment. Am J Med 1981; 71: 571–577
   PubMed Web of Science ®Google Scholar
• Robertson M J, Larson RA. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 1988; 84: 233–239
   PubMed Web of Science ®Google Scholar
• Walsh T J, Bulkley BH. Aspergillus pericarditis: Clinical and pathologic features in the immunocompromised patient. Cancer 1982; 49: 48–54
   PubMed Web of Science ®Google Scholar
• Andersson B S, Luna M A, McCredie KB. Systemic aspergillosis as cause of myocardial infarction. Cancer 1986; 58: 2146–2150
   PubMed Web of Science ®Google Scholar
• Gerson S L, Talbot G H, Hurwitz S, et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345–351
   PubMed Web of Science ®Google Scholar
• Gerson S L, Talbot G H, Lusk E, et al. Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol 1985; 3: 1109–1116
   PubMed Web of Science ®Google Scholar
• Gustafson T L, Schaffner W, Lavely GB, et al. Invasive aspergillosis in renal transplant recipients correlation with corticosteroid therapy. J Infect Dis 1983; 148: 230–238
   PubMed Web of Science ®Google Scholar
• Arnow P M, Anderson R L, Mainous PD, et al. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978; 118: 49–53
   PubMed Web of Science ®Google Scholar
• Aisner J, Schimpff S C, Bennett JE, et al. Aspergillus infection in cancer patients. Association with fire proofing material in a new hospital. J Am Med Assoc 1976; 235: 411–412
   PubMed Web of Science ®Google Scholar
• Sarubbi F A, Jr, Kopf H B, Wilson MB, et al. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction. Am Rev Respir Dis 1982; 125: 33–38
   PubMed Web of Science ®Google Scholar
• Opal S M, Asp A A, Cannady PB, et al. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 1986; 153: 634–637
   PubMed Web of Science ®Google Scholar
• Sherertz R J, Belani A, Kramer BS, et al. Impact of air filtration of nosocomial Aspergillus infections: Unique risk of bone marrow transplant recipients. Am J Med 1987; 83: 709–718
   PubMed Web of Science ®Google Scholar
• Kuhlman J E, Fishman E K, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: Characteristics findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985; 157: 611–614
   PubMed Web of Science ®Google Scholar
• Burch P A, Karp J E, Merz WG, et al. Favorable outcome of aspergillosis in patients with actue leukemia. J Clin Oncol 1987; 5: 1985–1993
   PubMed Web of Science ®Google Scholar
• Karp J E, Burch P, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988; 85: 203–209
   PubMed Web of Science ®Google Scholar
• Diamond RD. Cryptococcus neoformans. Principles and Practice of Infectious Diseases, GC Mandell, GR Douglas, JE Bennett. Wiley, New York 1985; 1460–1468
   Google Scholar
• Kaplan M H, Rosen P P, Armstrong D. Cryptococcosis in a cancer hospital. Cancer 1977; 39: 2265–2274
   PubMed Web of Science ®Google Scholar
• Fugita N K, Reynard M, Sapico FL, et al. Cryptococcal intracerebral mass lesions. Ann Intern Med 1981; 94: 382–388
   PubMedGoogle Scholar
• Perfect J R, Durack D T, Gallis HA. Cryptococcemia. Medicine 1983; 62: 98–109
   PubMed Web of Science ®Google Scholar
• Fisher B D, Armstrong D. Cryptococcal interstitial pneumonia. N Engl J Med 1977; 297: 1440–1441
   PubMed Web of Science ®Google Scholar
• Meunier-Carpentier F. Cryptococcal meningitis. Acta Clin Belg 1981; 36: 300–304
   PubMed Web of Science ®Google Scholar
• Diamond Rd., Bennett JE. Prognostic factors in cryptococcal meningitis. A study of 111 cases. Ann Intern Med 1974; 80: 176–181
   PubMed Web of Science ®Google Scholar
• Blazar Br., Hurd D D, Snover DC, et al. Invasive Fusarium infections in bone marrow transplant recipients. Am J Med 1984; 77: 645–651
   PubMed Web of Science ®Google Scholar
• Venditti M, Micozzi A, Gentile G, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis 1988; 10: 653–660
   PubMedGoogle Scholar
• Gold J, Poston W, Mertelsmann R, et al. Systemic infection with Trichosporon cutaneum in a patient with acute leukemia. Cancer 1981; 48: 2163–2167
   PubMed Web of Science ®Google Scholar
• Winston D, Basley G, Rhodes J, et al. Disseminated Trichosporon capitatum infection in an immunosuppressed host. Arch Intern Med 1977; 137: 1192–1195
   PubMed Web of Science ®Google Scholar
• Bennett JE. Miscellaneous fungi. Principles and Practice of Infectious Diseases, GC Mandell, GR Douglas, JE Bennett. Wiley, New York 1985; 1502–1504
   Google Scholar
• Yoo D, Lee H S, Kwong-Chung KJ. Brain abscesses due to Pseudoallescheria boydii associated with primary non-Hodgkin's lymphoma of the central nervous system: a case report and literature review. Rev Infect Dis 1985; 7: 272–277
   PubMedGoogle Scholar
• Lutwick L I, Galgiani J N, Johnson RH, et al. Visceral fungal infections due to Petriellidum boydii (Allerscheria boydii). In vitro sensitivity studies. Am J Med 1976; 61: 632–640
   PubMed Web of Science ®Google Scholar
• Enggrano I L, Hughes W T, Kalwinski DK, et al. Pseudoallerscheria in a patient with acute lymphoblastic leukemia. Arch Pathol Lab Med 1984; 108: 619–622
   PubMed Web of Science ®Google Scholar
• Shih L, Lee H. Disseminated petriellidiosis (allescheriasis) in a patient with refractory acute lymphoblastic leukemia. J Clin Pathol 1984; 37: 78–82
   PubMed Web of Science ®Google Scholar
• Meunier F. Fungal infections in the compromised hosts. Clinical Approach to Infection in the Compromised Host2nd ed., L Young. Plenum Medical, New York 1988; 193–220
   Google Scholar
• Kiehn T, Wong B, Edwards F, Armstrong D. Comparative recovery of bacteria and yeasts from lysis centrifugation and a conventional blood culture system. J Clin Microbiol 1983; 18: 300–304
   PubMed Web of Science ®Google Scholar
• Bille J, Edson R, Roberts G. Clinical evaluation of the lysis centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system. J Clin Microbiol 1984; 19: 126–128
   PubMed Web of Science ®Google Scholar
• Yu V L, Muder R R, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Am J Med 1986; 81: 249–254
   PubMed Web of Science ®Google Scholar
• Albelda S M, Talbot G H, Gerson SL, et al. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 1984; 76: 1027–1034
   PubMed Web of Science ®Google Scholar
• Stover D E, Zaman M B, Hadju SI, et al. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunocompromised host. Ann Intern Med 1984; 101: 1–7
   PubMed Web of Science ®Google Scholar
• Hageage G J, Harrington BJ. Use of calcofluor white in clinical mycology. Lab Med 1984; 15: 109–112
   Google Scholar
• Bennett JE. Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 1987; 9: 398–402
   PubMedGoogle Scholar
• Matthews R, Burnie J. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen. J Clin Microbiol 1988; 26: 459–463
   PubMed Web of Science ®Google Scholar
• Walsh T J, Newman K R, Moody M, et al. Trichosporonosis in patients with neoplastic disease. Medicine 1986; 65: 268–279
   PubMed Web of Science ®Google Scholar
• Westernink M AJ, Amsterdam D, Petell RJ, et al. Septicemia due to DF-2: cause of a false-positive cryptococcal latex agglutination result. Am J Med 1987; 83: 155–158
   PubMed Web of Science ®Google Scholar
• Pappagianis D, Collins M, Hector R, et al. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 1979; 16: 123–126
   PubMed Web of Science ®Google Scholar
• Powderly W G, Kobayashi G S, Herzig GP, et al. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 1988; 84: 826–832
   PubMed Web of Science ®Google Scholar
• Merz WG. Candida lusitaniae; frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 1984; 20: 1194–1195
   PubMed Web of Science ®Google Scholar
• Dick J D, Merz W G, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 1980; 18: 158–163
   PubMed Web of Science ®Google Scholar
• Bennett J E, Dismukes W E, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126–131
   PubMed Web of Science ®Google Scholar
• Dismukes W E, Cloud G, Gallis HA, et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317: 334–341
   PubMed Web of Science ®Google Scholar
• Meunier F, Gérain J, Snoeck R, . Fluconazole therapy of oropharyngeal candidiasis in cancer patients. Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, RA Fromtling, et al. JR Prous Science Publishers, Barcelona 1987; 169–174
   Google Scholar
• Van't Wout J W, van Furth R. A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. J Antimicrob Chemother 1988; 21: 665–672
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G. Liposomes as carriers of antimicrobial agents. Antimicrob Agents Chemother 1987; 31: 675–678
   PubMed Web of Science ®Google Scholar
• Meunier F, Klastersky J. Recent developments in prophylaxis and therapy of invasive fungal infections in granulocytopenic patients. Eur J Clin Oncol 1988; 24: 539–544
   PubMedGoogle Scholar
• Meunier F. New methods for delivery of antifungal agents. Rev Infect Dis 1989; 11: 51605–51612
   Google Scholar
• Lopez-Berestein G, Fainstein V, Hopfer R, et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 1985; 151: 704–710
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G, Bodey G P, Frankel LS, et al. Treatment of hepatosplenic fungal infections with liposomal amphotericin B. J Clin Oncol 1987; 5: 310–317
   PubMed Web of Science ®Google Scholar
• Sculier J P, Coune A, Meunier F, et al. Pilot study of amphotericin B entrapped into sonicated liposomes in cancer patients with fungal infections. Eur J Cancer Clin Oncol 1988; 24: 527–538
   PubMedGoogle Scholar
• Meunier F, Sculier J P, Coune A, . Amphotericin B encapsulated in liposomes adminstered to cancer patients. Proceedings of First International Conference on Drug Research in Immunologic and Infectious Diseases. Antifungal Drugs: Synthesis, Preclinical and Clinical Evaluation, V St Georgiev, et al. Annals of New York Academy of Sciences, New York 1989; vol. 544: 598–610
   Google Scholar
• Meunier F. Prevention of opportunistic mycoses in immunocompromised patients. Rev Infect Dis 1987; 9: 408–416
   PubMedGoogle Scholar
• Meunier F, Leleux A, Snoeck R, . Chemoprophylaxis of fungal infections. 1989. Diagnosis and Therapy of Systemic Fungal Infections, K. Holmberg, R. Meyer, et al. Raven Press, New York 1989; 167–177
   Google Scholar
• Pizzo P A, Robichaud K J, Gill FA, et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72: 101–111
   PubMed Web of Science ®Google Scholar
• Holleran W M, Wilbur J R, DeGregorio MG. Empiric amphotericin B therapy in patients with acute leukemia. Rev Infect Dis 1985; 7: 619–624
   PubMedGoogle Scholar
• EORTC International Antimicrobial Therapy Cooperative Group: Empirical antifungal therapy in febrile granulocytopenic patients. Am J Med 1989; 86: 668–672
   PubMed Web of Science ®Google Scholar